SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000885590-20-000016
Filing Date
2020-04-10
Accepted
2020-04-10 16:06:05
Documents
16
Effectiveness Date
2020-04-10

Document Format Files

Seq Description Document Type Size
1 DEFA14A defa14aapril102020doc.htm DEFA14A 66154
2 GRAPHIC defa14a04102020001.jpg GRAPHIC 56936
3 GRAPHIC defa14a04102020002.jpg GRAPHIC 167777
4 GRAPHIC defa14a04102020003.jpg GRAPHIC 136250
5 GRAPHIC defa14a04102020004.jpg GRAPHIC 52889
6 GRAPHIC defa14a04102020005.jpg GRAPHIC 68372
7 GRAPHIC defa14a04102020006.jpg GRAPHIC 132168
8 GRAPHIC defa14a04102020007.jpg GRAPHIC 144333
9 GRAPHIC defa14a04102020008.jpg GRAPHIC 115207
10 GRAPHIC defa14a04102020009.jpg GRAPHIC 87607
11 GRAPHIC defa14a04102020010.jpg GRAPHIC 131780
12 GRAPHIC defa14a04102020011.jpg GRAPHIC 159940
13 GRAPHIC defa14a04102020012.jpg GRAPHIC 36898
14 GRAPHIC defa14a04102020013.jpg GRAPHIC 33545
15 GRAPHIC defa14a04102020014.jpg GRAPHIC 179158
16 GRAPHIC defa14a04102020015.jpg GRAPHIC 184339
  Complete submission text file 0000885590-20-000016.txt   2392536
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-14956 | Film No.: 20786819
SIC: 2834 Pharmaceutical Preparations